Asahi Life Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Asahi Life Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,730	Closed	-$336K	–	187
2023 Q4	$336K	Buy	+2,730	New	+$341K	0.18%	117
2022 Q1	–	Sell	-2,970	Closed	-$378K	–	219
2021 Q4	$378K	Buy	2,970 +170	+6%	+$22.3K	0.05%	150
2021 Q3	$365K	Buy	+2,800	New	+$423K	0.05%	125
2020 Q3	–	Sell	-1,750	Closed	-$193K	–	257
2020 Q2	$193K	Buy	+1,750	New	+$194K	0.03%	168
2019 Q3	–	Sell	-2,530	Closed	-$361K	–	265
2019 Q2	$361K	Sell	2,530 -540	-18%	-$72.6K	0.07%	122
2019 Q1	$439K	Buy	+3,070	New	+$400K	0.07%	118

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Asahi Life Asset Management's JAZZ Position: Q1 2024 in Review

Asahi Life Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 2,730 shares — an estimated $336K sold.

Asahi Life Asset Management first reported a position in JAZZ in Q1 2019 and held it in 6 quarters. The position peaked at $439K in Q1 2019. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

Asahi Life Asset Management reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Asahi Life Asset Management sold 2,730 Jazz Pharmaceuticals shares in Q1 2024, an estimated $336K.
Asahi Life Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2019 and held it in 6 quarters.
Asahi Life Asset Management's Jazz Pharmaceuticals position peaked at $439K in Q1 2019.
481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Asahi Life Asset Management's 13F filing for Q1 2024, filed 3 May 2024.